Optimal Duration of First-Line Chemotherapy for Advanced Gastric Cancer: Data from the AGAMENON Registry
A study concludes that longer first-line chemotherapy regimens for patients with gastric cancer has a protective effect, and that discontinuing platinum chemo... Read More
The diagnostic value of serum gastrokine 1 (GKN1) protein in gastric cancer
A new study finds that levels of the protein gastrokine 1 (GKN1) in the blood can serve as a biomarker for identifying... Read More
In JAMA Oncology Publication, GeneDx Describes Lower Lifetime Risk of Gastric Cancer Conferred by CDH1
A study by GeneDx shows that the lifetime risk for gastric cancer in people with pathogenic CDH1 variants is 42% for men... Read More
Helicobacter pylori infection, chronic atrophic gastritis and riskof stomach and esophagus cancer: Results from the prospec tivepopulation-based ESTHER cohort study
A cohort study involving nearly 10,000 patients found that infection with H. Pylori in the presence of chronic atrophic gastritis was associated... Read More
Oxaliplatin Plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma in Combination With D2 Gastrectomy
A recent study found that the XELOX chemo regimen given before and after surgery in patients with locally advanced gastric cancer was... Read More
Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma
Adding Tykerb to chemotherapy in HER-2 positive gastric cancer patients was proven safe in a phase 2 trial
The association between self-reported poor oral health and gastrointestinal cancer risk in the UK Biobank: A large prospective cohort study
Some have suggested poor oral health raises the risk of gastric cancer, but a new analysis of more than 475,000 participants in... Read More
Role of vitamin D supplementation for primary prevention of cancer: Meta-analysis of randomized controlled trials.
A new analysis of multiple studies, presented at ASCO, suggests that Vitamin D may help decrease cancer-related mortality but that it has... Read More
Immune-Related Adverse Events and Efficacy of Checkpoint Inhibitors in Gastrointestinal Cancer
In a recent study, patients with gastrointestinal cancers who had immune-related adverse events while taking checkpoint inhibitors had progression-free survival of 32... Read More
Docetaxel, Oxaliplatin, and 5-Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma
A recent study in patients with metastatic gastric cancer showed that adding docetaxel to a modified FOLFOX7 chemo regimen produced a response... Read More
